Cargando…
Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
Calcium oxalate (CaOx) crystal‐induced nephropathies comprise a range of kidney disorders, for which there are no efficient pharmacological treatments. Although CaOx crystallization inhibitors have been suggested as a therapeutic modality already decades ago, limited progress has been made in the di...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175250/ https://www.ncbi.nlm.nih.gov/pubmed/32328427 http://dx.doi.org/10.1002/advs.201903337 |